↓ Skip to main content

Dove Medical Press

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway

Overview of attention for article published in OncoTargets and therapy, July 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
25 Mendeley
Title
miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway
Published in
OncoTargets and therapy, July 2018
DOI 10.2147/ott.s171043
Pubmed ID
Authors

Chuansheng Li, Jingwei Zhang, Zhongliang Ma, Fan Zhang, Wenlong Yu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 16%
Student > Bachelor 4 16%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Unspecified 1 4%
Other 3 12%
Unknown 9 36%
Readers by discipline Count As %
Medicine and Dentistry 5 20%
Biochemistry, Genetics and Molecular Biology 4 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Unspecified 1 4%
Veterinary Science and Veterinary Medicine 1 4%
Other 2 8%
Unknown 10 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2018.
All research outputs
#17,932,284
of 26,017,215 outputs
Outputs from OncoTargets and therapy
#1,190
of 3,040 outputs
Outputs of similar age
#225,802
of 345,148 outputs
Outputs of similar age from OncoTargets and therapy
#52
of 109 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,040 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,148 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.